Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adipose-derived Regenerative Cells for Congestive Heart Failure
NCT06705023Phase 2Recruiting
- Start
- Nov 2024
- Primary completion
- Oct 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous adipose-derived regenerative cells in Ischemic Heart Failure (IHF). Started Nov 2024; status: recruiting.
02
Drugs
autologous adipose-derived regenerative cells
03
Conditions
Ischemic Heart Failure (IHF)
Beyond the preview
Go deeper on NCT06705023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06705023.